NCT01798056 2021-05-13Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyGlaxoSmithKlinePhase 3 Completed237 enrolled 20 charts